Emerging Opportunities in GLP-1 Drug Development

added blog Home

2026-10-26 17:42:14 -

Valued at USD 61.89 billion in 2025, the GLP-1 Receptor Agonist Market is estimated at USD 70.21 billion in 2026 and is projected to reach USD 257.12 billion by 2034, registering a CAGR of 17.14% during 2026–2034. North America led the market in 2025 with a 75.46% revenue share, while Asia Pacific is projected to grow at a 14.1% CAGR. Ozempic accounted for 32.15% of the market in 2025....

0 Comments 0 Shares 32 Views 0 Reviews